GLUCOSE TOLERANCE TEST: FOR THE DIAGNOSIS OF DIABETES MELLITUS

Similar documents
NHS Greater Glasgow & Clyde Managed Clinical Network for Diabetes

Glucose Tolerance Test (Non Pregnant Adult)

Diagnostic criteria for diabetes Routine cases and Non-diabetic hyperglycaemia adapted with permission from Royal Devon and Exeter

CONTENTS. 1. Health and Safety Personnel and Training Requirements Purpose of the Test Principle Of the Test...

Diabetes Mellitus. Eiman Ali Basheir. Mob: /1/2019

GESTATIONAL DIABETES MELLITUS AND SUBSEQUENT MANAGEMENT OF CONFIRMED GESTATIONAL DIABETES MELLITUS (GDM) AND SELECTIVE SCREENING - CLINICAL GUIDELINE

Diabetes Mellitus (DM) Chronic metabolic disorder with a predisposition of hyperglycaemia (increased blood glucose).

WARD INSTRUCTIONS WEBSITE

DIABETES 20/02/2014 WHAT IS DIABETES? GLUCOSE WHAT IS DIABETES? GLUCOSE HOMEOSTASIS GLUCOSE METABOLISM

NHS Highland Diabetes Managed Clinical Network Newsletter. Welcome to this issue of the NHS Highland Diabetes MCN Newsletter. (October 2016).

Service Specification

Acute Stroke - Management of Hyperglycaemia. Contents

Guideline for the Management of Diabetes in Pregnancy

Chapter 14 Elderly, Home and Long-term Care Collections. Objectives:

Gestational Diabetes Mellitus (GDM) and Diabetes in Pregnancy: Diagnostic Recommendations, NSLHD

Sandra Božičević dipl. ing. med. biochem, Marijana Vučić Lovrenčić, PhD Vuk Vrhovac University Clinic, Zagreb, Croatia

HbA1c: what the GP needs to know

Trust Guidelines for the Diagnosis and Management of Gestational Diabetes Mellitus (GDM)

Referral to Adult Diabetes Specialist Services

Barns Medical Practice Service Specification: Diabetes

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Diabetes in Pregnancy Registrar Induction. Dr Anna Dover August 31 st 2015

Lynda Astbury Lead Diabetes Specialist Nurse

There have been important changes in diabetes care which may not be covered in undergraduate textbooks.

A S Y N T H E S I Z E D H A N D B O O K ON G E S T A T I O N A L D I A B E T E S

Diabetes Diagnosis 2011 Does your patient have diabetes?

PACKAGE LEAFLET: INFORMATION FOR THE USER. Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate)

ESM Table 2 Data extraction form and key data from included studies

Dept of Diabetes Main Desk

Prevention and Management of Hypoglycaemia of the Breastfed Newborn Reference Number:

Chronic Benefit Application Form Cardiovascular Disease and Diabetes

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)

Southern Derbyshire Shared Care Pathology Guidelines. Primary Hyperparathyroidism

Southern Derbyshire Shared Care Pathology Guidelines. Hypocalcaemia in Adults

Monitoring in Type 2 Diabetes. Learning Outcomes. Type 2 Diabetes. Senga Hunter Community Diabetes Specialist Nurse

SUMMARY OF PRODUCT CHARACTERISTICS

Sample Pages. Glycated Haemoglobin (HbA1c) Testing Market,

Frailty and Type 2 Diabetes Guidelines for clinicians

Supplementary Online Content

PACKAGE LEAFLET: INFORMATION FOR THE USER. <PRODUCT NAME> 600 mg / 1,000 IU orodispersible tablets. Calcium/cholecalciferol (Vitamin D3)

A CLINICAL STUDY OF GESTATIONAL DIABETES MELLITUS IN A TEACHING HOSPITAL IN KERALA Baiju Sam Jacob 1, Girija Devi K 2, V.

Integrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014

WILL YOU USE HBA1C TO SCREEN & MONITOR DIABETES? Dr. Amany Mousa

APPLICATION FORM CHRONIC MEDICINE BENEFIT 2019

PERIOPERATIVE DIABETES GUIDELINE

Guidelines to assist General Practitioners in the Management of Type 2 Diabetes. April 2010

MODULE 8B: Management of Group B Dengue with Warning Signs or Dengue with Co-existing Conditions

Diabetes and Pregnancy

PACKAGE LEAFLET: Information for the user. METFORMINE Film-coated tablets 500 mg, 850 mg or 1000 mg (Metformin hydrochloride)

GUIDELINE FOR THE MANAGEMENT OF HYPOGLYCAEMIA IN ADULTS WITH DIABETES MELLITUS

MANAGEMENT OF DIABETES IN PREGNANCY

Hypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg

Warwickshire Dietetic Service Referral Criteria

Type 2 Diabetes. Stopping Smoking. Consider referral to smoking cessation. Consider referring for weight management advice.

PACKAGE LEAFLET: INFORMATION FOR THE USER

The contractor establishes and maintains a register of patients with AF

TUEC Guidelines Medical Information to Support the Decisions of TUE Committees Diabetes Mellitus DIABETES MELLITUS

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

New indicators to be added to the NICE menu for the QOF and amendments to existing indicators

HYPONATRAEMIA GUIDELINES

NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST: Clinical Chemistry Guidelines

Joint Trust Guideline for 72 hour fast for investigation of spontaneous hypoglycaemia in adults For use in:

DIABETES Self Directed Test (12 Hours) Name: Ward/Practice Area: Mailing Address:

Blood Glucose and Hyperglycaemia Management in Hospital for Adults with Diabetes Clinical Guideline V2.0. March 2018

DR HJ BODANSKY MD FRCP CONSULTANT PHYSICIAN LEEDS TEACHING HOSPITALS ASSOCIATE PROFESSOR, UNIVERSITY OF LEEDS

Postnatal Care for Women with Type 1 or Type 2 Diabetes

Aetiology, Diagnosis and classification of Diabetes mellitus

egfr > 50 (n = 13,916)

GUIDELINES FOR THE MANAGEMENT OF DIABETES IN PALLIATIVE CARE

Awareness About Diabetes in Diabetic Patients and General Population

Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)

MANAGING MEALTIME INSULIN

Evaluation of first trimester fasting blood glucose as a predictor of gestational diabetes mellitus

2. PRESCRIPTION STATUS/RESTRICTION OF SALES TO PHARMACIES ONLY 3. COMPOSITION OF THE MEDICINAL PRODUCT

BIOT221 Western Diagnostic Techniques

Diabetes Emergency Caesarean section or other unplanned surgery (GL822)

Diabetes in Pregnancy. L.Sekhavat MD

Diabetes mellitus - diagnosis, classification and acute complications. David Karásek 3rd Department of Internal Medicine University Hospital Olomouc

Placename CCG. Policies for the Commissioning of Healthcare

MANAGEMENT OF DIABETES MELLITUS (DM) IN PREGNANCY TYPE 1, TYPE 2 AND GESTATIONAL DIABETES (GDM),CLINICAL GUIDELINE. V1.0

IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS

Lecture. By Dr Ale A.O Lecturer. Consultant Physician/Endocrinologist.

To study the incidence of gestational diabetes mellitus and risk factors associated with GDM

DERBY-BURTON LOCAL CANCER NETWORK FILENAME Lenalidomide_MDS.DOC CONTROLLED DOC NO: HCCPG B78 CSIS Regimen Name: LEN_MDS.

CAUTION: You must refer to the intranet for the most recent version of this procedural document.

Glucose Tolerance Test. Women s and Children s Services

Coronary Heart Disease and Stroke, Primary and Secondary Prevention Guidelines (Cholesterol)

Shared Care Guideline Metolazone for fluid management in CKD (Adults)

Diabetes Mellitus Type 2

Elements for a public summary

SUMMARY OF PRODUCT CHARACTERISTICS. One chewable tablet contains 1250 mg calcium carbonate (equivalent to 500 mg calcium).

Stapleton, Mary; Daly, Niamh; O'Kelly, Ruth; Turner, Michael.

GESTATIONAL DIABETES: An Overview

Autonomic neuropathy

University College Hospital. Blood glucose and HbA 1 c targets

Diabetes in Pregnancy Registrar Induction Programme. Dr Anna Dover August 29 th 2016

Date of submission April 2016 Amended January 2018

Medicines Optimisation Team Standard Operating procedure for Alogliptin Audit:

Transcription:

Title of Document: Glucose tolerance test: For Diagnosis of Mellitus Authoriser: Leila Cornes Page 1 of 6 GLUCOSE TOLERANCE TEST: FOR THE DIAGNOSIS OF DIABETES MELLITUS Introduction In most cases mellitus can be diagnosed using either fasting glucose or HbA1c. Diagnosis of diabetes must be based on either glucose or HbA1c but not a combination of the two. Diagnostic algorithms for glucose based diagnosis of diabetes mellitus and glucose intolerance (WHO 2006) and for HbA1c based diagnosis of diabetes mellitus (WHO 2011) are shown in Appendix A and B of this document. Note the cut-offs used locally are different to the WHO criteria applied to the non-pregnant population and are included, along with guidance on reporting by the duty biochemist in Appendix C. Principle Following the oral administration of a standard dose of glucose, the plasma glucose concentration normally rises but returns towards the fasting level within 2 hours. If insulin activity is reduced the plasma glucose concentration takes longer than 2 hours to return to normal. Preparation 1) The patient should be on a normal carbohydrate diet (at least 150g per day) for at least 3 days before the test. 2) It is desirable to postpone the test if the patient is febrile, is within 6 weeks of a myocardial infarction or major surgery or is on short-term treatment with drugs which impair glucose tolerance, such as glucocorticoids, thiazide diuretics, beta blockers, loop diuretics, progesterone and oestrogen. 3) The patient should fast from 10 p.m. on the evening before the test with the exception of drinks of water and any drugs which he/she normally takes. 4) During the test the patient should be resting and should not smoke, eat or drink, except for glasses of water. Procedure 1) At about 9 am take 2mls venous blood into a fluoride oxalate (grey top) bottle. Note the time of the specimen on the bottle and the request form/electronic request. 2) Give the patient 75 g of glucose. This can be given in 3 different ways: a) Polycal liquid (Nutricia Clinical). This is available on prescription. The instructions below should be followed: 113ml Polycal liquid made up to a volume of 200ml in a beaker with water, shaken thoroughly and consumed over a 5 minute period followed by a further 100ml plain water

Title of Document: Glucose tolerance test: For Diagnosis of Mellitus Authoriser: Leila Cornes Page 2 of 6 b) Rapilose: Adults (including the elderly): 300ml to be consumed over a period of 5-10 minutes Children: for children weighing less than 43kg the dosage should be reduced based on child s body mass; the dose is 7ml of solution per kg of body weight up to a maximum 300ml c) Anhydrous glucose 75 g dissolved in 300 ml water 3) The patient needs to rest and not smoke for 2 hours until the post glucose samples are taken. 4) Take one further 2mls venous blood sample into a fluoride oxalate bottle 120 minutes after the glucose was given. Note the time of the specimen on the bottle and the request form/electronic request. 4) The test is now complete and the patient may eat. If the patient vomits during the test, stop the test. 5) Send both blood specimens with the request form (if applicable). Interpretation (Non pregnancy) If the above procedure is followed, venous plasma glucose is measured and the WHO criteria are as follows: Venous plasma glucose concentrations (mmol/l) Classification Fasting 2 Hours Normal < 6.1 and < 7.8 Mellitus 7.0 or 11.1 Impaired glucose tolerance < 7.0 and 7.8-11.0 Impaired fasting glucose 6.1-6.9 and < 7.8 NB. The above criteria apply to venous plasma. If venous whole blood or capillary blood is used, different criteria apply. Please contact laboratory. Local diagnostic criteria in pregnancy The local maternity guidelines use a venous fasting range of 5.5 7.0 mmol/l and a 2 hour range of 7.8 11 mmol/l to define impaired glucose tolerance. There is no separate category for impaired fasting glucose and the fasting cut-off used to define normal results is lower than the WHO guidelines. A flow chart outlining the protocol is included at the end of this document. GTT comment An automatic comment will be put on all GTT results: : Fasting glucose >7.0 mmol/l or 2hr glucose >11.0mmol/L Impaired glucose tolerance: 2hr glucose 7.8-11.0mmol/L Impaired fasting glucose: Fasting glucose 6.1-6.9mmol/L (>5.5mmol/L in pregnancy)

Title of Document: Glucose tolerance test: For Diagnosis of Mellitus Authoriser: Leila Cornes Page 3 of 6 In pregnancy, all abnormal results, including impaired fasting glucose, should be referred to the antenatal clinic within 72hrs (telephone No. 0117 3235310) Please see local maternity guidelines for referral pathways. References Definition and diagnosis of Mellitus and intermediate hyperglycaemia. Geneva WHO 2006 Use of Glycated Haemoglobin (HbA1c) in the diagnosis of Mellitus WHO 2011

Title of Document: Glucose tolerance test: For Diagnosis of Mellitus Authoriser: Leila Cornes Page 4 of 6 Appendix A. Diagnostic algorithm for glucose based diagnosis of diabetes mellitus and glucose intolerance (WHO 2006) excluded <5.5 mmol/l Random glucose (if 11.1 mmol/l done) 5.6 11.0 mmol/l excluded <6.1 mmol/l Fasting glucose 7.0 mmol/l 6.1 6.9 mmol/l Impaired Fasting Glycaemia 2h glucose <7.8 mmol/l Oral Glucose Tolerance Test 2h glucose 11.1 mmol/l 2h glucose 7.8-11 mmol/l Impaired Glucose Tolerance Fasting glucose is recommended as the initial diagnostic test where feasible. In the absence of classical symptoms, (thirst, polyuria and unexplained weight loss) at least two diagnostic glucose results on different days are essential. If discordant results are obtained, either fasting (if reliable) or 2h OGTT value may be diagnostic, but re-testing after an interval is recommended. Tests should not be carried out during intercurrent illness or periods of stress as this may result in false positive results. Impaired Glucose Tolerance and Impaired Fasting Glycaemia carry increased risk of progression to diabetes recommended re-assess in one year.

Title of Document: Glucose tolerance test: For Diagnosis of Mellitus Authoriser: Leila Cornes Page 5 of 6 Appendix B. Diagnostic algorithm for HbA1c based diagnosis of diabetes mellitus (WHO 2011) unlikely <42 mmol/mol Measure HbA1c 48 mmol/mol Probable diabetes Reassess in 3 years if high risk 42-47 mmol/mol Increased diabetes and CV risk Reassess in 1 year High diabetes and CV risk Reassess in 6 months <48 mmol /mol Repeat HbA1c within 2 weeks Confirmed 48 mmol/mol HbA1c must not be used if hyperglycaemia has developed rapidly, for example: Possible Type 1 diabetes Symptomatic children and young adults Symptoms less than three months Acutely ill patients Medication that may cause rapid rise in glucose e.g. corticosteroids, antipsychotics Acute pancreatic damage or pancreatic surgery HbA1c must not be used in the presence of factors affecting HbA1c formation or measurement. These include: Iron and vitamin B 12 deficiency Haemolytic anaemias Administration of iron, vitamin B 12 or erythropoietin Chronic liver disease Chronic renal failure (CKD 4 and 5) Alcoholism Rheumatoid arthritis Splenomagaly or splenectomy Haemoglobinopathies Drugs that may affect erythrocyte lifespan e.g. antiretrovirals, ribavarin, dapsone HbA1c must not be used to diagnose diabetes in pregnancy

Title of Document: Glucose tolerance test: For Diagnosis of Mellitus Authoriser: Leila Cornes Page 6 of 6 Appendix C Screening for in Pregnancy (local protocol) ++/+++ Glycosuria at any routine AN visit TIMED GLUCOSE Within 2 hours of eating > 2 hours after eating Within 2 hours of eating > 2 hours after eating Glucose <7 Glucose <5.5 Glucose >7 Glucose >5.5 Normal Abnormal No further action GTT Fasting >7 or 2hr >11.0 Fasting 5.5-7.0 or 2hr 7.8-11.0 Fasting <5.5 or 2hr <7.8 Diabetic Urgent referral to Med ANC. Telephone 35310 Impaired Referral within 72 hours to Med ANC Normal No action required